Babar Ghias
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Babar Ghias is currently President & Director at Astria Therapeutics, Inc. since 2026.
Mr. Ghias is Chief Financial Officer at BioCryst Pharmaceuticals, Inc. since 2025.
Mr. Ghias is Chief Operating Officer at Castle Creek Biosciences, Inc. Former positions include Director at MyoTherix, Inc., Chief Financial Officer at AvenCell Therapeutics, Inc., and Vice President-Corporate Development at Marathon Pharmaceuticals LLC.
Education includes an undergraduate degree from Lahore University of Management Sciences and an MBA from Washington University in St. Louis.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-12-2025 | 268.700 ( 0,11% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 07-07-2025 |
| ASTRIA THERAPEUTICS, INC. | President | 23-01-2026 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Operationeel Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
MyoTherix, Inc.
MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Directeur/Bestuurslid | - |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for treatment of cancers | Financieel Directeur/CFO | - |
Marathon Pharmaceuticals LLC
Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Marathon Pharmaceuticals LLC
Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Lahore University of Management Sciences
Lahore University of Management Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyoTherix, Inc.
MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for treatment of cancers | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau